Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-01

FDA Approved: VENLAFAXINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA granted supplemental approval for venlafaxine from Zydus Lifesciences Limited, signaling an approved modification to an existing generic drug application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)